Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 5, 2014, Pages 618-626

  Ersboll A S ^a   Hedegaard, M ^a   Sondergaard L ^a   Ersboll M ^a   Johansen, M ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Beta blockers; birthweight; heart disease; pregnancy; small for gestational age

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; LABETALOL; METOPROLOL; PINDOLOL; PROPRANOLOL; SOTALOL;

ARTICLE; BIRTH WEIGHT; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HEART DISEASE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYDRONEPHROSIS; HYPOSPADIAS; INTRAUTERINE GROWTH RETARDATION; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MARFAN SYNDROME; MATERNAL AGE; PES EQUINOVARUS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING HABIT; TACHYCARDIA; TREATMENT DURATION; ADULT; CASE CONTROL STUDY; CHEMICALLY INDUCED; HEART DISEASES; NEWBORN; ORAL DRUG ADMINISTRATION; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FETAL GROWTH RETARDATION; HEART DISEASES; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 84899466097     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12522     Document Type: Article

References (28)

1. Gelson E, Curry R, Gatzoulis MA, Swan L, Lupton M, Steer P, et al. Effect of maternal heart disease on fetal growth. Obstet Gynecol 2011; 117: 886-91. Erratum in: Obstet Gynecol. 2011; 118(2 Pt 1):364.
2. Hameed A, Karaalp IS, Tummala PP, Wani OR, Canetti M, Akhter MW, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001; 37: 893-9. (Pubitemid 32202460)
3. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg M,. Pregnancy outcomes in women with congenital heart disease. Circulation 2006; 113: 517-24.
4. Siu SC, Colman JM, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002; 105: 2179-84. (Pubitemid 34517162)
5. Siu SC, Sermer M, Colman JM, Alvarez N, Mercier L-A, Morton BC, et al. Prospective multicentre study of pregnancy outcomes in women with heart disease. Circulation 2001; 104: 515-21. (Pubitemid 32738118)
6. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJM, et al. Outcome of pregnancy in women with congenital heart disease. J Am Coll Cardiol 2001; 49: 2303-11.
7. McIntire DD, Bloom SL, Casey BM, Leveno KJ,. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340: 1234-8. (Pubitemid 29181643)
8. Barker DJP,. In utero programming of chronic disease. Clin Sci 1998; 95: 115-28. (Pubitemid 28401260)
9. Nakhai-Pour HR, Rey E, Bérard A,. Antihypertensive medication use during pregnancy and the risk for major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol 2010; 89: 147-54.
10. Lydakis C, Lip GYH, Beevers M, Beevers DG,. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999; 12: 541-7. (Pubitemid 29268384)
11. Magee LA, Duley L,. Oral beta-blockers for mild to moderate hypertension during pregnancy (Review). Cochrane Database Syst Rev 2003;(3):CD002863.
12. Meidahl Petersen K, Jimenez-Solem E, Andersen JT, Petersen M, Brødbæk K, Køber L, et al. β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open 2012; 2: e001185.
13. Magee LA, Ornstein MP, von Dadelszen P,. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318: 1332-6. (Pubitemid 29219050)
14. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ,. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007;(1):CD002252.
15. Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, et al. Risk of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf 2011; 20: 138-45.
16. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee L,. Fall in mean arterial blood pressure and fetal growth restriction in pregnancy: a meta-analysis. Lancet 2000; 355: 87-92. (Pubitemid 30068551)
17. Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T, Walkinshaw S,. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011; 72: 394-401.
18. Regitz-Zagrosek V, Lundqvist CB, Borghi C, Cifkova R, Ferreira R, Foidart J-M, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 3147-97.
19. Roos-Hesselink J, Ruys TPE, Stein JI, Thilén U, Webb GD, Niwa K, et al. Outcome of pregnancy in patients with structural or ischemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 2013; 34: 657-65.
20. Thorne S, Nelson-Piercy C, MacGregor A, Gibbs A, Crowhurst J, Panay N, et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 2006; 32: 75-81.
21. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH,. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8. (Pubitemid 29299976)
22. Knudsen LB, Olsen J,. The Danish medical birth registry. Dan Med Bull 1998; 45: 320-3. (Pubitemid 28313542)
23. Marsal K, Persson H-P, Larsen T, Lilja T, Selbing A, Sultan B,. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843-8. (Pubitemid 26267023)
24. Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC,. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97: 1206-12.
25. Lidar M, Langevitz P,. Pregnancy issues in scleroderma. Autoimmun Rev 2012; 11: A515-9.
26. Williams D, Davison J,. Chronic kidney disease in pregnancy. BMJ 2008; 336: 211-5.
27. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2012; 97: 2543-65.
28. Falkay G, Melis K, Kovács L,. Correlation between beta- and alpha-adrenergic receptor concentrations in human placenta. J Recept Res 1994; 14: 187-95. (Pubitemid 24160745)